Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)

Constantine S. Tam, Susan O'Brien, William Plunkett, William Wierda, Alessandra Ferrajoli, Xuemei Wang, Kim Anh Do, Jorge Cortes, Issa Khouri, Hagop Kantarjian, Susan Lerner, Michael J. Keating

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint Dive into the research topics of 'Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds